These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31339174)

  • 1. Rate or Rhythm Control in Older Atrial Fibrillation Patients: Risk of Fall-Related Injuries and Syncope.
    Dalgaard F; Pallisgaard JL; Numé AK; Lindhardt TB; Gislason GH; Torp-Pedersen C; Ruwald MH
    J Am Geriatr Soc; 2019 Oct; 67(10):2023-2030. PubMed ID: 31339174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate and rhythm therapy in patients with atrial fibrillation and the risk of pacing and bradyarrhythmia.
    Dalgaard F; Pallisgaard JL; Lindhardt TB; Torp-Pedersen C; Gislason GH; Ruwald MH
    Heart Rhythm; 2019 Sep; 16(9):1348-1356. PubMed ID: 31125673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate-control treatment and mortality in atrial fibrillation.
    Chao TF; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
    Circulation; 2015 Oct; 132(17):1604-12. PubMed ID: 26384160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between serum potassium levels and short-term mortality in patients with atrial fibrillation or flutter co-treated with diuretics and rate- or rhythm-controlling drugs.
    Hagengaard L; Søgaard P; Espersen M; Sessa M; Lund PE; Krogager ML; Torp-Pedersen C; Kragholm KH; Polcwiartek C
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):137-144. PubMed ID: 31263883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Heart Rate Control Medications for the Treatment of Sepsis-Associated Atrial Fibrillation.
    Bosch NA; Rucci JM; Massaro JM; Winter MR; Quinn EK; Chon KH; McManus DD; Walkey AJ
    Chest; 2021 Apr; 159(4):1452-1459. PubMed ID: 33619010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice Patterns and Outcomes of Treatments for Atrial Fibrillation During Sepsis: A Propensity-Matched Cohort Study.
    Walkey AJ; Evans SR; Winter MR; Benjamin EJ
    Chest; 2016 Jan; 149(1):74-83. PubMed ID: 26270396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S
    Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic drug therapy among patients presenting to emergency department with symptomatic atrial fibrillation - a prospective nationwide cohort.
    Penttilä T; Mäkynen H; Hartikainen J; Hyppölä H; Lauri T; Lehto M; Lund J; Raatikainen MJP;
    Scand J Trauma Resusc Emerg Med; 2017 Aug; 25(1):81. PubMed ID: 28810904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic use from 1991 to 2007: insights from the Canadian Registry of Atrial Fibrillation (CARAF I and II).
    Andrade JG; Connolly SJ; Dorian P; Green M; Humphries KH; Klein GJ; Sheldon R; Talajic M; Kerr CR
    Heart Rhythm; 2010 Sep; 7(9):1171-7. PubMed ID: 20430112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-World Comparison of Classes IC and III Antiarrhythmic Drugs as an Initial Rhythm Control Strategy in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
    Kipp R; Askari M; Fan J; Field ME; Turakhia MP
    JACC Clin Electrophysiol; 2019 Feb; 5(2):231-241. PubMed ID: 30784696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation.
    Olshansky B; Rosenfeld LE; Warner AL; Solomon AJ; O'Neill G; Sharma A; Platia E; Feld GK; Akiyama T; Brodsky MA; Greene HL;
    J Am Coll Cardiol; 2004 Apr; 43(7):1201-8. PubMed ID: 15063430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular arrhythmia and death among atrial fibrillation patients using anti-arrhythmic drugs.
    Friberg L
    Am Heart J; 2018 Nov; 205():118-127. PubMed ID: 30236980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Antiarrhythmic Drug Therapy With Syncope and Pacemaker Implantation in Patients With Atrial Fibrillation.
    Kim YG; Lee HS; Kim H; Kim M; Jeong JH; Choi YY; Shim J; Choi JI; Kim YH
    J Am Coll Cardiol; 2024 Mar; 83(11):1027-1038. PubMed ID: 38479951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation pharmacotherapy after hospital discharge between 1995 and 2004: a shift towards beta-blockers.
    Hansen ML; Gadsbøll N; Gislason GH; Abildstrom SZ; Schramm TK; Folke F; Friberg J; Sørensen R; Rasmussen S; Poulsen HE; Køber L; Madsen M; Torp-Pedersen C
    Europace; 2008 Apr; 10(4):395-402. PubMed ID: 18258807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study.
    Corley SD; Epstein AE; DiMarco JP; Domanski MJ; Geller N; Greene HL; Josephson RA; Kellen JC; Klein RC; Krahn AD; Mickel M; Mitchell LB; Nelson JD; Rosenberg Y; Schron E; Shemanski L; Waldo AL; Wyse DG;
    Circulation; 2004 Mar; 109(12):1509-13. PubMed ID: 15007003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses.
    Saksena S; Slee A; Waldo AL; Freemantle N; Reynolds M; Rosenberg Y; Rathod S; Grant S; Thomas E; Wyse DG
    J Am Coll Cardiol; 2011 Nov; 58(19):1975-85. PubMed ID: 22032709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of post-discharge fall-related injuries among adult patients with syncope: A nationwide cohort study.
    Numé AK; Carlson N; Gerds TA; Holm E; Pallisgaard J; Søndergaard KB; Hansen ML; Vinther M; Hansen J; Gislason G; Torp-Pedersen C; Ruwald MH
    PLoS One; 2018; 13(11):e0206936. PubMed ID: 30462687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital.
    Allen Lapointe NM; Sun JL; Kaplan S; d'Almada P; Al-Khatib SM
    Am J Cardiol; 2008 Apr; 101(8):1134-41. PubMed ID: 18394447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Obesity-Mediated Atrial Fibrillation and Therapy With Sodium Channel Blocker Antiarrhythmic Drugs.
    Ornelas-Loredo A; Kany S; Abraham V; Alzahrani Z; Darbar FA; Sridhar A; Ahmed M; Alamar I; Menon A; Zhang M; Chen Y; Hong L; Konda S; Darbar D
    JAMA Cardiol; 2020 Jan; 5(1):57-64. PubMed ID: 31774463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.